Japanese researchers from the Osaka University Graduate School of Medicine recently found that lipid-lowering medications containing fibrates may reduce diabetic retinopathy risk. Using data from nearly 85,000 type 2 diabetes patients, they found that 7.4% of those who received lipid-lowering medications developed diabetic retinopathy. This was compared to 11.4% of patients who developed diabetic retinopathy but did not receive lipid-lowering drugs.
This study also found that lipid-lowering medications reduced the need for treatment by 35% among patients who had already developed diabetic retinopathy. The need for vitrectomy and laser photocoagulation was reduced by 52% and 35%, respectively.
These findings were published in Diabetes, Obesity, and Metabolism on September 10, 2018.